T. Rowe Price Investment Management, Inc. Third Harmonic Bio, Inc. Call Options Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding THRD
# of Institutions
83Shares Held
43.6MCall Options Held
7.1KPut Options Held
0-
Atlas Venture Life Science Advisors, LLC10.9MShares$118 Million18.24% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.78MShares$62.6 Million1.85% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$47.3 Million1.88% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.18MShares$34.5 Million1.87% of portfolio
-
General Atlantic LLC New York, NY2.96MShares$32.1 Million1.15% of portfolio
About Third Harmonic Bio, Inc.
- Ticker THRD
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,328,900
- Market Cap $437M